A detailed history of Rise Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Rise Advisors, LLC holds 1,267 shares of ABBV stock, worth $215,833. This represents 0.12% of its overall portfolio holdings.

Number of Shares
1,267
Previous 1,257 0.8%
Holding current value
$215,833
Previous $215,000 16.28%
% of portfolio
0.12%
Previous 0.11%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$163.84 - $199.33 $1,638 - $1,993
10 Added 0.8%
1,267 $250,000
Q2 2024

Jul 09, 2024

BUY
$154.79 - $180.76 $3,714 - $4,338
24 Added 1.95%
1,257 $215,000
Q1 2024

Apr 09, 2024

BUY
$159.82 - $182.1 $149,112 - $169,899
933 Added 311.0%
1,233 $224,000
Q4 2023

Jan 10, 2024

SELL
$137.6 - $154.97 $3,027 - $3,409
-22 Reduced 6.83%
300 $46,000
Q3 2023

Oct 10, 2023

SELL
$133.59 - $154.65 $294,432 - $340,848
-2,204 Reduced 87.25%
322 $47,000
Q2 2023

Jul 10, 2023

SELL
$132.51 - $164.9 $13,516 - $16,819
-102 Reduced 3.88%
2,526 $340,000
Q1 2023

Apr 05, 2023

BUY
$144.61 - $166.54 $867 - $999
6 Added 0.23%
2,628 $418,000
Q4 2022

Jan 06, 2023

BUY
$138.31 - $165.87 $276 - $331
2 Added 0.08%
2,622 $0
Q3 2022

Oct 11, 2022

BUY
$134.21 - $153.93 $402 - $461
3 Added 0.11%
2,620 $352,000
Q2 2022

Jul 28, 2022

BUY
$137.62 - $174.96 $8,394 - $10,672
61 Added 2.39%
2,617 $401,000
Q1 2022

Apr 22, 2022

SELL
$131.98 - $163.75 $30,751 - $38,153
-233 Reduced 8.35%
2,556 $414,000
Q4 2021

Feb 24, 2022

BUY
$107.43 - $135.93 $299,622 - $379,108
2,789 New
2,789 $378 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Rise Advisors, LLC Portfolio

Follow Rise Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rise Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rise Advisors, LLC with notifications on news.